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Abstract In this study, eight commercially available, chemi-
cally defined Chinese hamster ovary (CHO) cell culture media
from different vendors were evaluated in batch culture using
an IgG-producing CHO DG44 cell line as a model. Medium
adaptation revealed that the occurrence of even small aggre-
gates might be a good indicator of cell growth performance in
subsequent high cell density cultures. Batch experiments con-
firmed that the culture medium has a significant impact on
bioprocess performance, but high amino acid concentrations
alone were not sufficient to ensure superior cell growth and
high antibody production. However, some key amino acids
that were limiting in most media could be identified.
Unbalanced glucose and amino acids led to high cell-
specific lactate and ammonium production rates. In some me-
dia, persistently high glucose concentrations probably induced
the suppression of respiration and oxidative phosphorylation,
known as Crabtree effect, which resulted in high cell-specific
glycolysis rates along with a continuous and high lactate pro-
duction. In additional experiments, two of the eight basal me-
dia were supplemented with feeds from two different manu-
facturers in six combinations, in order to understand the com-
bined impact of media and feeds on cell metabolism in a CHO
fed-batch process. Cell growth, nutrient consumption and me-
tabolite production rates, antibody production, and IgG qual-
ity were evaluated in detail. Concentrated feed supplements
boosted cell concentrations almost threefold and antibody ti-
ters up to sevenfold. Depending on the fed-batch strategy,
fourfold higher peak cell concentrations and eightfold in-
creased IgG titers (up to 5.8 g/L) were achieved. The glyco-
lytic flux was remarkably similar among the fed-batches;
however, substantially different specific lactate production
rates were observed in the different media and feed combina-
tions. Further analysis revealed that in addition to the feed
additives, the basal medium can make a considerable contri-
bution to the ammonium metabolism of the cells. The glyco-
sylation of the recombinant antibody was influenced by the
selection of basal medium and feeds. Differences of up to
50 % in the monogalacto-fucosylated (G1F) and high man-
nose fraction of the IgG were observed.
Keywords Chinese hamster ovary (CHO) . Cell culture
medium . Antibody production . Batch . Fed-batch .Medium
benchmarking
Introduction
Chinese hamster ovary (CHO) cells have become the standard
mammalian host cell line for more than 70 % of recombinant
protein pharmaceuticals on the market (Jayapal et al. 2007).
This dominant position originates from their long history of
use along with beneficial attributes such as their ability to
express complex proteins, to conduct appropriate post-
translational modifications, and their capability to secrete
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proteins into the cell culture supernatant, which facilitates
downstream processing.
Since the first use of CHO cells for recombinant protein
expression, production processes have steadily improved
through advances in cell line development, clone screening
and isolation, and optimization of basal media and feed sup-
plements, as well as enhanced process monitoring and control.
Compared to earlier processes, these developments allow 10-
fold higher peak cell concentrations to be reached and product
titers of up to 5 g/L are routinely achieved within 2 weeks of
process duration (Jayapal et al. 2007; Yu et al. 2011).
Optimized feed compositions and regimens improve culture
longevity. They also lead to a more efficient cell metabolism,
which reduces the formation of metabolites such as ammoni-
um and lactate that may negatively affect growth, viability,
product formation, and product quality (Butler 2005).
Medium composition and development of an appropriate feed
strategy is crucial, as excessive nutrient concentrations can be
detrimental to cells due to component concentration depen-
dent toxicity and high osmolality (Yu et al. 2011).
During the last years, several serum-free and chemically
defined CHO-specific cell culture media have become avail-
able as well as some media systems that combine basal medi-
um and feeds. However there is a need to understand the
effects on cell metabolism and protein quality better when
using different combinations of commercial basal media and
feeds. In this study, we performed batch and fed-batch cultures
with commercially available CHO cell culture media and
feeds that were selected based on their novelty and widespread
use. The lack of published data examining the way in which
cell metabolism as well as antibody production and quality in
a fed-batch culture are affected by different combinations of
commercial basal media and feeds, encouraged us to test such
combinations from two vendors. The influence on cell growth
and antibody production of a recombinant CHO DG44 cell
line was evaluated. Spent media were analyzed to evaluate the
impact of the different media formulations on cell-specific
nutrient utilization and formation of metabolic by-products.
Finally, the effect of the different fed-batch strategies on the
glycosylation of the recombinant IgG was also investigated.
Materials and methods
Maintenance culture and batch experiments
A CHO DG44 cell line (licensed from Cellca GmbH,
Laupheim, Germany) was used as a model cell line. The cells
were thawed and propagated in ActiCHO™ SMmedium (GE
Healthcare) supplemented with 6 mML-glutamine and 30 nM
methotrexate (both Sigma-Aldrich). In routine culture and
batch experiments, cells were inoculated at a cell concentra-
tion of 2×105 cells/mL, using a working volume of 35 mL in
125-mL Erlenmeyer shake flasks (Corning). Cultures were
grown in an ISF1-X incubator shaker (Kuhner) at 37 °C,
140 rpm, 7 % CO2, and 90 % humidity. The cells were pas-
saged every 3–4 days. Adaptation to new media was done
through at least five consecutive passages, until a stable
growth rate had been achieved. The media investigated were
CD CHO, CD OptiCHO™, CD FortiCHO™ (all Life
Technologies), Ex-Cell™ CD CHO (Sigma Aldrich),
ProCHO™5 (Lonza), BalanCD™ CHO Growth A (Irvine
Scientific), Cellvento™ CHO-100 (EMD Millipore), and
ActiCHO™ P (GE Healthcare). After adaptation to the new
media, batch cultures were started and sampled daily as de-
scribed below. Cultures were terminated once the viability
dropped below 60 %.
Fed-batch cultures
Fed-batch cultures were grown in 500-mL Erlenmeyer shake
flasks (Corning) at a starting volume of 100 mL. The inocu-
lum concentration was 3×105 cells/mL applying the same
culture conditions as described for batch cultures. All fed-
batch cultures were run in triplicates with feeding regimen
as shown in Table 1. During the feed phase, cells adapted to
ActiCHO P and OptiCHO media were supplemented with
ActiCHO Feed A and Feed B (both GE Healthcare) and
CHO CD EfficientFeed™ A (Life Technologies), respective-
ly, according to the manufacturer’s recommendation.
Additionally, the feeds were exchanged and used to supple-
ment the other basal medium to investigate the effect on cul-
ture performance. Furthermore, FunctionMAX™ Titer
Enhancer (Life Technologies) was added to fed-batch process-
es with both basal media to test its applicability as universal
titer enhancer (Barrett et al. 2012). In all fed-batch experi-
ments, a concentrated glucose solution (250 g/L; Sigma-
Aldrich) was used to maintain the concentration of this nutri-
ent above 3 g/L. Cultures were terminated once the viability
dropped below 60 %.
Analyses
Each day, 2 mL of sample was drawn from the batch and fed-
batch cultures for analysis of cell concentration, viability, an-
tibody titer, and metabolite concentrations. The cell concen-
tration was quantified using a Z2 Coulter Counter™
(Beckman Coulter), and the viability was determined by
trypan blue dye exclusion with a Neubauer improved
haemocytometer (MedPro).
Recombinant antibody concentration was determined by
Bio-Layer Interferometry on an Octet™ QK (fortéBio). For
IgG analysis, Protein A (ProA) biosensors (fortéBio) at 30 °C
in phosphate buffered saline (PBS) with 1000 rpm agitation
were used. Experimental curves were recorded for the indi-
vidual samples, and data was processed and analyzed using
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the Octet data analysis software 6.4 (fortéBio). Finally, sam-
ples were quantified by alignment with a standard curve gen-
erated from serial dilutions of affinity-purified antibody prod-
uct. The concentrations of key metabolites (i.e., glucose, glu-
tamine, glutamic acid, lactate, and ammonium) were deter-
mined using a BioProfile™ 100 Plus (Nova Biomedical).
Osmolality was measured in fed-batch cultures by freezing
point depression using an Osmomat 030 (Gonotec).
Amino acid concentrations (except proline (Pro) and cys-
teine (Cys)) in media, feed supplements, and selected samples
were analyzed at the end of the exponential growth phase and
when a culture was terminated, using a high-performance liq-
uid chromatography method. Briefly, protein in the samples
was precipitated with 5-sulfosalicylic acid (Alfa Aesar) and
the supernatant was subsequently cleared using a 0.2-μm filter
unit (Sartorius). Free amino acids reacted with ortho-
phthalaldehyde (Pierce) in an automated pre-column derivati-
zation method and were then separated on a ZORBAX™
Eclipse Plus C18 column (Agilent) at 25 °C using a flow rate
of 1.0 mL/min. After gradient elution using 50 mM sodium
acetate pH 5.7 and acetonitrile (Merck), amino acids were
excited at 340 nm and the fluorescence signal was detected
at 450 nm. Samples were quantified applying 3-(2-thienyl)-
DL-alanine (Fluka) as an internal standard.
Glycoprofiling was performed to investigate oligosaccha-
ride distribution of antibody product upon harvest from fed-
batch cultures. The cell suspension was centrifuged at 170g,
the supernatant clarified using a 0.22-μm filter (Express
PLUS, Merck Millipore) and diluted with PBS to a concen-
tration of 1 to 2 mg/mL. N-glycan profiles of the Fc regions of
the monoclonal antibodies were determined by IdeS proteo-
lytic digestion and electrospray mass spectrometry as de-
scribed by Chevreux et al. (2011). Fc fragment signals with
masses corresponding to N-glycan isoforms G0, G0F, G0F-
GN, G1F-GN, G1F, G2F, G1F+SA1, G2F+SA1, G2F+SA2,
Man5 to Man9, Man9+Glc, and Man-9+2Glc were investi-
gated, and their relative abundance rates were estimated from
the intensity of the signals. Signals for N-glycan isoforms G1
and G2 were not amenable to quantification as their masses




In batch experiments, the impact of the culture medium on cell
growth and antibody concentrations, as well as the process
duration, was evaluated (Fig. 1a, b). A summary of the data
generated from the batch cultures is given in Table 2. The
highest cell concentrations were obtained in ActiCHO P
(8.5×106 cells/mL) and BalanCD (9.0×106 cells/mL). In
ActiCHO P, the cultures had a slightly higher growth rate
and the maximal cell concentration peaked 2 days earlier than
in BalanCD. However, in ActiCHO P, the cell concentration
declined quickly after reaching its maximum, while a more
pronounced plateau phase of about 3 days was observed in
BalanCD. In ProCHO5, Cellvento CHO-100 and OptiCHO
cell concentrations reached 4–5×106 cells/mL. Although
growth appeared to be similar in those three media until day
6, a drastic viability drop in ProCHO5 led to culture termina-
tion on day 7. In the other two media, the viability of the
culture remained above 60 % during 4 further days. In Ex-
Cell CD CHO, cells grew to cell concentrations (2.6×106
cells/mL) which were about 70 % lower compared to
ActiCHO P and BalanCD. The formation of small aggregates
of 5 to 10 cells was observed in CD CHO as well as
FortiCHO. In CD CHO, a maximum cell concentration of
2.5×106 cells/mL was reached after 12 days. In FortiCHO,
the cells barely grew and reached a maximum cell concentra-
tion of 6.0×105 cells/mL during a process time of 9 days.
Not surprisingly, antibody production was also influenced
by the cell culture media (Fig. 1b). In general, high cell con-
centrations correlated well with high titers. Therefore, the
highest IgG concentrations were reached in ActiCHO P with
863 and 778 mg/L in BalanCD. About 500 mg/L was
achieved in OptiCHO, Ex-Cell CD CHO, and Cellvento
CHO-100. Batch cultures in ProCHO5 and CD CHO reached
384 and 334 mg/L, respectively. Due to the low cell concen-
trations in FortiCHO medium, quantification of IgG was not
applicable.
Lactate production differed considerably among the tested
media. Typically, the maximum concentrations were reached









ActiCHO P 3 Feed A (daily; 3 %) Feed B (daily; 0.3 %)
ActiCHO P 3 Feed A (daily; 3 %) Feed B (daily; 0.3 %) and FunctionMAX (3, 5, 7; 3.3 %)
CD OptiCHO 3 EfficientFeed A (3, 5, 7, 9; 10 %) None
CD OptiCHO 3 EfficientFeed A (3, 5, 7; 10 %) None
CD OptiCHO 3 EfficientFeed A (3, 5, 7; 10 %) FunctionMAX (3, 5, 7; 3.3 %)
CD OptiCHO 3 Feed A (daily; 3 %) Feed B (daily; 0.3 %)
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during the initial 3 or 4 days of the cell culture as shown in
Fig. 1c. The highest peak lactate concentrations were observed
in CDCHO (2.2 g/L) and FortiCHO (2.1 g/L). In these media,
the lactate concentrations remained high until the end of the
culture. In OptiCHO, Ex-Cell CD CHO, BalanCD, Cellvento
CHO-100, and ActiCHO P, lactate accumulated to concentra-
tions between 1.0 and 1.8 g/L but was subsequently con-
sumed. Ammonium levels increased continuously throughout
Fig. 1 a Cell and b antibody concentrations as well as c lactate and d ammonium levels obtained with commercial CHO cell culture media in batch
mode
Table 2 Process relevant data from batch cultures
Medium ActiCHO P CD CHO CD OptiCHO Ex-Cell CD CHO ProCHO5 BalanCD Cellvento
CHO-100
CD FortiCHO
Peak cell conc. (106 cells/mL) 8.5 2.5 3.9 2.6 4.5 9.0 4.9 0.6
Antibody conc. (mg/L) 863 334 522 510 384 778 503 n.d.
μ exponential phase (1/d) 0.70 0.52 0.41 0.42 0.47 0.49 0.41 0.31
qP exp. phase (pg/(cell×day)) 49.6 71.8 49.1 44.6 53.4 44.4 30.4 n.d.
qP whole process (pg/(cell×day)) 41.9 42.7 35.2 36.8 49.9 29.3 28.5 n.d.
STY (mg/(L×d)) 121 28 46 44 51 76 45 n.d.
qGlucose (pg/(cell×day)) −368 −482 −446 −434 −319 −149 −237 −647
qLactate (pg/(cell×day)) 142 421 221 168 296 103 93 485
qGlutamate (pg/(cell×day)) −19 −6 −13 −2 8 22 −3 3
qGlutamine (pg/(cell×day)) −83 −85 −89 −80 −143 −72 −82 −99
qAmmonium (pg/(cell×day)) 7 20 10 13 16 12 11 21
All values have been calculated as mean
STY space-time yield, n.d. not determined
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the batch cultures, reaching concentrations of between 80 and
180 mg/L (Fig. 1d).
The high lactate concentrations of cultures grown in
FortiCHO and CD CHO correlated well with elevated cell-
specific lactate production rates of 485 and 421 pg/cell/day,
respectively (Table 2). In addition, FortiCHO and CD CHO
media triggered the highest specific glucose consumption
rates. In all other media, lactate was consumed during the late
stages of the culture, and 55–80 % lower specific lactate pro-
duction rates, as well as lower glucose consumption rates,
were observed compared with FortiCHO and CD CHO. The
lowest glucose to lactate conversion rate, about 40 %, was
seen in ActiCHO P, Ex-Cell CD CHO, and Cellvento CHO-
100. At the other extreme, cells in ProCHO 5 converted 92 %
of the consumed glucose to lactate. The mean specific ammo-
nium production rates in the different media were 14±7 pg/
cell/day. The specific rates were highest for cultures in CD
CHO and FortiCHO, media where no high cell concentrations
were reached.
Residual amino acid concentrations were quantified at two
time points: at the end of the exponential growth phase and at
culture termination when the viability was below 60 %.
Concentrations were compared to the composition of the cul-
tivation medium used. To identify limiting amino acids, an
arbitrary cutoff of 20 % compared with the initial medium
concentration was set. As shown in Table 3B, glutamine
(Gln) was exhausted in all media at the end of exponential
growth phase. Limitations of other amino acids varied among
the tested media. Tyrosine (Tyr), serine (Ser), aspartic acid
(Asp), and asparagine (Asn) appeared most critical.
Increased concentrations of alanine (Ala) and glycine (Gly)
were observed in all media. Glutamic acid (Glu) concentra-
tions increased only in ProCHO5, Ex-Cell CD CHO, and
BalanCD while Asp concentrations increased in Ex-Cell CD
CHO and Cellvento CHO-100.
Fed-batch cultures
During the fed-batch experiments, we aimed to investigate the
influence of feed additives on the culture performance using
two basal media based on their performance in the initial batch
culture. Moreover, we evaluated whether feed supplements
had similar effects when used with different basal media.
The different media and feed combinations are shown in
Table 1. During batch cultivation, the highest cell and anti-
body concentrations were obtained in ActiCHO P and
BalanCD medium. However, supplementary fed-batch exper-
iments using BalanCD and the medium’s recommended feed
substrate, Feed 1 (Irvine Scientific), resulted in lower cell
concentrations compared to the batch culture despite a 5-day
prolonged process (data not shown). Compared with the batch
culture, the fed-batch increased the IgG yield by about 40% to
1.2 g/L. In contrast, OptiCHO performed well with more than
one feed option (Barrett et al. 2012). These preliminary exper-
iments convinced us to apply OptiCHO for subsequent fed-
batch experiments including various feed combinations.
The composition of basal media and feeds had a substantial
effect on peak cell concentrations and antibody titers as shown
in Fig. 2a, b. The highest cell and product concentrations of
2.39×107 cells/mL and 5.5 g/L were achieved in cultures
grown in ActiCHO P supplemented with Feed A and B.
Feeding these cultures additionally with FunctionMAX al-
tered the process only marginally reaching peak cell concen-
trations of 2.13×107 cells/mL and IgG titers of 5.8 g/L. Fed-
batch cultures in OptiCHO achieved 40 % or less of the peak
cell concentration observed in fed-batch cultures with
ActiCHO P as a base medium. Cell growth was lowest when
cultures were grown in OptiCHO and fed with EfficientFeed
A only, irrespective of whether the feed was added during 7 or
9 days (5.76 or 5.74×106 cells/mL, respectively). When cul-
tures in OptiCHO were supplemented with Feed A and B,
25 % higher cell concentrations (9.03×106 cells/mL) were
obtained than when supplemented with EfficientFeed A and
FunctionMAX together (6.80×106 cells/mL). In OptiCHO,
the final titers were highest when combining EfficientFeed
A and FunctionMAX as feed substrates (1.7 g/L). Slightly less
product (1.5 g/L) was obtained when cells were supplemented
with Feeds A and B, however, with the benefit of a 4-day
shorter culture duration. Substantially lower product concen-
trations where observed in OptiCHO cultures fed with
EfficientFeed A alone, irrespective of whether feeding lasted
until day 7 or 9 (0.8 and 0.7 g/L, respectively).
All fed-batch cultures reached their plateau phase after a
process time of 5 to 7 days and the specific growth rate de-
clined thereafter (data not shown). During the initial 7 days,
the average growth rate was highest in ActiCHO P fed-batch
cultures supplemented with Feed A and B (0.63±0.00 day−1),
and ActiCHO P fed with Feed A and B together with
FunctionMAX (0.65±0.02 day−1) as shown in Table 4. In
OptiCHO fed-batch cultures, the average growth rates were
about 30 % lower. When supplemented with Feed A and B,
cells in this medium grew at an average rate of 0.46±
0.01 day−1; this was followed by cultures fed with
EfficientFeed A and FunctionMAX (0.43±0.03 day−1).
Finally, cultures supplemented with EfficientFeed A had
growth rates of 0.38±0.02 and 0.40±0.04 day−1 when fed
during 7 and 9 days, respectively.
The highest cell-specific antibody productivities were ob-
tained in ActiCHO P fed-batches. Processes using Feeds A
and B yielded an average qP of 51.2 pg/cell/day during the
initial 7 days (Table 4). A further supplementation with
FunctionMAX did not increase the average qP (51.2 pg/cell/
day). Fed-batch cultures in OptiCHO reached 20 to 40% low-
er specific productivities compared with the ActiCHO P cul-
tures. Supplementation with EfficientFeed A and
FunctionMAX or with Feeds A and B resulted in similar
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Table 3 (A) Cumulative amino acid concentrations without proline and
cysteine of commercial CHO cell media. Percentage of amino acids in the
sample compared to the initial medium concentration at the end of the
exponential growth phase and at culture termination of (B) batch and (C)
fed-batch experiments. Dark gray scale indicates amino acids which
increased during the cultivation (cutoff=120 %); light gray scale





































































































































Asp 41% 17% 64% 6% 92% 84% 208% 15% 98% 122% 57% 40% 132% 104%
Glu 14% 9% 33% 19% 382% 406% 151% 22% 84% 80% 418% 519% 118% 97%
Asn 34% 3% 23% 1% 49% 33% 27% 1% 66% 11% 23% 2% 61% 5%
Ser 23% 20% 10% 9% 39% 31% 12% 10% 53% 17% 26% 26% 51% 29%
His 62% 58% 61% 55% 69% 65% 56% 40% 86% 82% 74% 80% 93% 85%
Gln 2% 1% 1% 4% 2% 4% 2% 6% 9% 20% 3% 3% 3% 15%
Gly 318% 406% 736% 919% 152% 160% 289% 329% 6590% 14281% 265% 348% 136% 164%
Thr 66% 64% 57% 50% 96% 94% 57% 40% 87% 85% 70% 75% 100% 96%
Arg 26% 23% 51% 48% 94% 93% 70% 66% 86% 83% 97% 107% 88% 87%
Ala 707% 1361% 3085% 2716% 1081% 1130% 552% 631% 4718% 6735% 106% 140% 198% 163%
Tyr 20% 13% 31% 19% 66% 61% 40% 19% 78% 62% 22% 21% 63% 34%
Val 56% 50% 52% 40% 41% 30% 45% 23% 83% 78% 19% 16% 88% 79%
Met 55% 51% 45% 31% 72% 68% 23% 0% 71% 50% 0% 0% 82% 69%
Trp 68% 56% 78% 61% 69% 62% 69% 45% 84% 81% 24% 22% 88% 79%
Ile 61% 52% 66% 54% 87% 82% 61% 41% 85% 84% 57% 53% 89% 85%
Phe 50% 48% 51% 43% 0% 0% 43% 23% 82% 74% 17% 16% 94% 88%
Leu 55% 46% 56% 43% 76% 72% 40% 18% 83% 78% 41% 35% 74% 54%
Lys 38% 46% 59% 44% 91% 88% 65% 24% 80% 75% 62% 64% 86% 79%












































































































































































































Asp 46% 132% 174% 585% 102% 77% 98% 3% 261% 122% 270% 1578%
Glu 52% 138% 162% 490% 94% 89% 62% 2% 178% 303% 475% 1751%
Asn 7% 1% 53% 19% 95% 7% 205% 2% 365% 2% 316% 442%
Ser 31% 58% 97% 275% 60% 214% 88% 124% 259% 128% 202% 1401%
His 44% 81% 95% 186% 136% 241% 104% 188% 143% 174% 99% 384%
Gln 13% 2% 17% 36% 1% 99% 13% 59% 11% 10% 15% 271%
Gly 188% 536% 261% 297% 956% 419% 160% 419% 201% 570% 181% 446%
Thr 81% 163% 129% 285% 130% 425% 178% 328% 250% 320% 268% 1233%
Arg 35% 170% 140% 429% 113% 407% 168% 321% 268% 395% 216% 1031%
Ala 3420% 2620% 5362% 12601% 2135% 109% 371% 100% 427% 198% 419% 1101%
Tyr 106% 268% 276% 602% 51% 32% 26% 16% 130% 176% 198% 1260%
Val 81% 176% 158% 337% 113% 442% 187% 325% 322% 449% 354% 1753%
Met 31% 62% 79% 157% 95% 129% 61% 99% 95% 103% 81% 361%
Trp 65% 104% 108% 181% 149% 245% 125% 188% 157% 169% 142% 534%
Ile 62% 111% 127% 241% 117% 441% 219% 322% 335% 446% 271% 1067%
Phe 122% 277% 226% 530% 121% 245% 107% 188% 193% 261% 252% 1280%
Leu 59% 109% 148% 271% 121% 591% 285% 425% 524% 738% 395% 1715%
Lys 114% 350% 289% 809% 318% 432% 202% 344% 278% 289% 267% 1150%
Total 56% 116% 128% 287% 99% 150% 86% 112% 142% 157% 143% 606%
A
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values of 36.7 and 39.3 pg/cell/day, respectively. The lowest
specific productivities were observed when OptiCHO was
only supplemented with EfficientFeed A for 7 (29.9 pg/cell/
day) or 9 days (31.7 pg/cell/day). The volumetric productivity
(space-time yield, STY) differed among the fed-batch cultures
as shown in Table 4. This is a consequence of the different cell
concentrations and cell-specific productivities. The highest
STY was obtained in ActiCHO P fed with Feed A and B
(335 mg/L/day) or further supplemented with FunctionMAX
(282 mg/L/day). The second best performing strategies, but
already 70 % lower, were OptiCHO supplemented with Feed
A and B alone (97 mg/L/day) or combining EfficientFeed A
with FunctionMAX (82 mg/L/day). Another 50 % reduced
STY was obtained when OptiCHO was fed with
EfficientFeed A for 7 or 9 days (50 and 51 mg/L/day,
respectively).
The concentrations of lactate, glutamic acid, and ammoni-
um are shown in Fig. 2d–f. Lactate peaked on day 2 or 3 in all
cultures and was later consumed to levels below 1 g/L. After
day 6, lactate concentrations were considerably lower in
OptiCHO fed-batches than in ActiCHO P. However, when
cells in OptiCHO were fed with Feed A and B, a continuous
increase of lactate to 4.2 g/L was observed after the end of
exponential growth phase. Additionally, using this combina-
tion, up to 2.4 g/L glutamic acid accumulated, whereas in all
other fed-batch cultures, its concentration remained below
0.7 g/L. Glutamine was readily consumed within the first 3
to 5 days in all fed-batch cultures (data not shown).
Ammonium accumulated following a similar trend in all
fed-batch cultures during the initial 5 days, after which the
concentration of this metabolite increased faster in OptiCHO
cultures than in ActiCHO P. This was caused by the ele-
vated cell-specific ammonium production in OptiCHO
cultures during the plateau phase. From day 7 until
day 10, it was up to six times higher in OptiCHO cul-
tures than in ActiCHO P (data not shown). This resulted
in similar absolute ammonium concentrations of 0.30 to
0.34 g/L in both media despite the lower cell concen-
trations in OptiCHO. Notably, cultures grown in
OptiCHO and supplemented with Feed A and B reached
the highest ammonium concentrations (0.41 g/L).
The evaluated feed combinations resulted in substantial
osmolality differences as shown in Fig. 2c. The highest values
were observed in OptiCHO fed with Feed A and B. In this
case, the osmolality rose above 400 mOsm/kg on day 9; dur-
ing the following 6 days, it increased further, reaching a max-
imum of 610 mOsm/kg, whereas the osmolality in all other
fed-batch cultures in OptiCHO remained 40 to 55 % lower at
levels of 280 to 350 mOsm/kg. The ActiCHO P fed-batch
cultures fed with Feed A and B or additionally with
FunctionMAX also passed a threshold of 400 mOsm/kg on
days 13 and 8, respectively. However, in case of feeding with
Feed A and B only, a maximum of 440 mOsm/kg was reached
on day 14; when FunctionMAX was added, the osmolality
peaked on the last day (day 18) at 520 mOsm/kg.
The residual percentage of amino acids compared to their
original concentration in the respective cell culture medium at
the end of the exponential growth phase and at the end of the
process is shown in Table 3C. The residual concentrations in
all fed-batch cultures barely dropped below critical levels. Gln
was the only amino acid that decreased below 20 % of its
original medium concentration in all fed-batch experiments
at the end of the exponential growth phase. Additionally, in
OptiCHO cultures fed with EfficientFeed A, low levels of
Asp, Glu, and Tyr were observed. During the feed phase,
several amino acids accumulated, especially toward the end
of the process. The medium/feed combination with the lowest
amino acid accumulations was ActiCHO P with Feeds A and
B where 3 (exponential phase) and 10 (harvest of culture)
amino acids exceeded their original medium concentrations.
This was followed by OptiCHO fed with EfficientFeed A
during 9 and 7 days, where 8/13 and 10/11 amino acids, re-
spectively, accumulated. When cultures in ActiCHO P were
fed with Feed A and B together with FunctionMAX, 12/16
amino acids accumulated. When the cell line was grown in
OptiCHO and fed with EfficientFeed A as well as
FunctionMAX, 15/16 amino acids accumulated. The highest
residual amino acid concentrations were observed in fed-batch
cultures in OptiCHO medium supplemented with Feed A and
B, where 15/18 amino acids were overfed.
The impact of the diverse fed-batch combinations on prod-
uct glycosylation was investigated upon culture harvest. The
glycan pattern of the antibody was determined at high resolu-
tion, and all major N-glycans were detected with good signal-
to-noise ratios (data not shown). As illustrated in Fig. 3, anti-
body glycosylation varied among the fed-batches. However,
the main glycan structures had a similar distribution with core
fucosylated agalacto glycans (G0F) being most prevalent (48–
66 %), followed by monogalacto (G1F; 17–36 %) and
digalacto (G2F; 3–7 %) glycans. The percentage of high man-
nose structures (Man5) ranged between 3 and 9 %.
Discussion
During the intial study in batch culture, a CHODG44 cell line
expressing a recombinant IgG was grown in eight commer-
cially available CHO cell culture media. Our main goal was to
investigate the effect of different CHO cell culture media on
cell metabolism and antibody production. During adaptation
to the different media, aggregates of 5 to 10 cells were ob-
served in CD CHO and FortiCHO. Despite showing constant
growth rates in the adaptation cultures, the cells in these two
media did not grow to high concentrations. Under suboptimal
culture conditions, cells may undergo apoptosis, which causes
the release of DNA from dead and decaying cells. This
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promotes cell-cell adhesion and ultimately leads to the forma-
tion of cell clusters or aggregates. Cell aggregation is detri-
mental to a bioprocess and has been shown to reduce the
specific growth rate by up to 50 % and increase cell-specific
death rates due to exerting higher shear forces on large aggre-
gates than on single cells (Renner et al. 1993). In our case, cell
aggregation was less pronounced during the adaptation phase,
most likely due to the regular medium exchange two times per
week and relatively high viabilities of >95 %. Since viability
and cell growth seemed reasonable during the adaptation
phase, the occurrence of even small aggregates might be a
good indicator of cell growth performance in subsequent high
cell density cultures where the negative effect of cell cluster-
ing may be enhanced.
Cell and antibody concentrations during batch experiments
correlated well (Fig. 1a, b). Consequently, high cell concen-
trations resulted in the highest titers. Lactate production dif-
fered considerably among the cultures. Media with high cell-
Fig. 2 a Cell and b antibody concentrations, c osmolality, d lactate, e ammonium, and f glutamic acid concentrations obtained with commercial CHO
media in fed-batch mode. All values represent the mean of three replicate experiments. Error bars show 1 standard deviation
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specific lactate production rates coincided well with high ab-
solute concentrations (Fig. 1c and Table 2). The increasing
lactate concentration, perhaps in combination with the forma-
tion of small aggregates during medium adaptation in CD
CHO and FortiCHO, might also provide evidence for subop-
timal cell performance in these media. Lactate is a major by-
product of cell culture that causes acidification of the medium.
In bioprocesses, the pH is neutralized by the addition of base
which increases the osmolality and can lead to a reduction in
cell growth, viability, and recombinant protein yields. One
way to reduce lactate formation is to maintain a low residual
glucose concentration, which has been shown to shift the cell
metabolism to more efficient pathways in BHK (Cruz et al.
1999), hybridoma (Zhou et al. 1995), and CHO (Fan et al.
2014) cell cultures. For BHK cells, Cruz et al. (1999) showed
that this shift occurs at glucose levels below 1 mM. Yet all
selected media contained glucose above this level, which may
account for the high glycolytic activities together with high
initial lactate productivities that we associated with an in-
creased growth of CHO cells, similar to previous observations
(Li et al. 2012).
The energetically inefficient metabolism which was ob-
served may be attributed to the Crabtree effect. Here, elevated
glucose concentrations inhibit oxygen consumption, which
results in aerobic glycolysis and lactate formation. It has been
shown that some cancer cells can regulate their energy metab-
olism and reversibly switch between fermentation and oxida-
tive metabolism, depending on the absence or presence of
glucose and environmental conditions (Diaz-Ruiz et al.
2011). A pronounced cell-specific glycolysis rate was deter-
mined, especially for batch cultures in FortiCHO and CD
CHO (Table 2), at which the main fraction of glucose suppos-
edly did not enter the citric acid cycle and oxidative phosphor-
ylation but was merely metabolized via pyruvate to lactate
(Table 2). A Crabtree effect seemed reasonable since higher
glucose concentrations coincided with higher lactate produc-
tion rates (data not shown). These rates decreased with de-
creasing glucose concentrations until they became negative,
indicating lactate consumption, when glucose was used up.
Glucose concentrations remained high in CD CHO and
FortiCHO and, therefore, a persistent glucose-induced sup-
pression of respiration and oxidative phosphorylation
(Crabtree effect) resulted in continuous production of lactate.
Another possible explanation for this could be an unbalanced
nutrient supply for the respective cell line, which might lead to
cellular stress and suboptimal growth which in turn leads to
increased secretion of by-products. Indeed, an unbalanced
supply of glucose and amino acids has recently been shown
to lead to high lactate and ammonium concentrations, which
inhibited CHO cell growth in a fed-batch culture (Fan et al.
2014). Interestingly, cells in CD CHO and FortiCHO also had
the highest specific ammonium production rates among all
investigated cultures (Table 2). Concerning amino acids, we
observed that 38–76 % were still abundant at culture termina-
tion compared to the total initial medium concentration
(Table 3B). Higher amino acid consumption rates often coin-
cided with higher final antibody titers and higher viable cu-
mulative cell days (data not shown). Therefore, not only the
concentration of single amino acids but also the reduction of
the total amino acid supply may serve as an indicator for their
balance. Another potential explanation, although not analyzed
in this study, could be related to copper, which has been iden-
tified as a critical medium component in CHO cell cultures.
Too low concentrations of copper in culture media can lead to
reduced cell concentrations and the accumulation of lactate,
with no subsequent consumption of this metabolite. On the
contrary, high copper concentrations may lower the cell-
specific glucose consumption rate and result in less lactate
production (Luo et al. 2012).
Quantification of residual amino acid concentrations in the
media is important as their availability is seen to be strongly
linked to recombinant protein expression (Jordan et al. 2013).
Remarkably, at the end of the exponential growth phase, cells
had consumed roughly half and in somemedia only less than a
quarter of the total initial amino acids (Table 3B). Despite
some variations, Gln was consumed in all media and occa-
sionally Glu, Tyr, Ser, Phe, Val, and Met were also consumed.
As Tyr and Ser were proposed to be important factors for cell
growth (Kim et al. 1998; González-Leal et al. 2011; Jordan
et al. 2013), andMet has been described as an important donor
of sulfur and methyl groups for efficient recombinant protein
production (Kim et al. 2005), it would be interesting to see
whether elevating their concentrations prolongs the exponen-
tial growth phase. Between the end of the exponential growth
phase and the end of the process, the total amino acid concen-
tration dropped by another 3 to 16 %, and several of the 18
amino acids which were analyzed reached limiting concentra-
tions. Although amino acid utilization is specific for individ-
ual cell lines, culture conditions, and biological products
(Jayme 1991), we and others repeatedly found Asn (in six
media), Ser (four), Tyr (three), and Asp (three) to be limiting
(Chen et al. 2000; Altamirano et al. 2006; González-Leal et al.
Fig. 3 Antibody glycoform distribution at harvest during fed-batch
cultivation in different commercial CHO media
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2011; Jordan et al. 2013). Therefore, somewhat higher con-
centrations might be beneficial in terms of cell growth and
productivity. As observed previously (Chen et al. 2000;
Xing et al. 2011), Ala and Gly were produced in all media.
Gly has been shown to improve CHO cell growth (Chen and
Harcum 2005), but high concentrations of Ala were found to
affect biomass production negatively by signaling that inter-
mediates produced from TCA cycle are abundant. Thus,
only a minimal supply of Ala should be applied to
prevent inhibition of pyruvate kinase and the TCA path-
way (Xing et al. 2011).
In summary, our results show that high amino acid concen-
trations alone are not sufficient to support high cell growth and
antibody production. This was further corroborated by testing
a chemically defined in-house prototype medium in which up
to three-fold higher amino acid concentrations were used. Cell
culture in this prototype medium did not result in a corre-
sponding improvement of biomass or IgG concentration (data
not shown). Likewise, ProCHO5, CD CHO, and ActiCHO P
contained similar total amino acid concentrations, but the out-
come of the respective cell cultures differed significantly with
respect to cell concentration and IgG titer. Despite the fact that
the total amino acid consumption was found to be surprisingly
low in some media (Table 3A), which certainly still allows for
optimization, our data suggest that it is not the total amount of
amino acids that is critical for cell growth and recombinant
antibody production but rather a balanced medium composi-
tion that meets the needs of the cell line used.
In a follow-up study, the impact of the basal medium for-
mulation on fed-batch cultures and the effect of different feed
supplements on cell growth, metabolism, recombinant protein
production, and IgG glycosylation were evaluated. Fed-batch
experiments demonstrated the beneficial effect of feed solu-
tions tailored to certain commercial media. Compared with the
batch cultures, the peak cell concentrations increased by 280
and 230 %, titers by 670 and 330 %, and volumetric produc-
tivities (STY) by 260 and 200 %, and finally, the cell culture
process was extended by 11 or 8 days in ActiCHO P and
OptiCHOmedia, respectively. In general, nutrient supplemen-
tation of the basal media had a positive effect on cell growth
and titers, although a well-balanced basal medium was funda-
mental, even for the best performing feed supplements, to
reach peak cell concentrations around day 7 and maintain
antibody secretion until the end of the cell culture (Fig. 2).
ActiCHO P supplemented with Feed A and B yielded
higher titers than OptiCHO in combination with the same
feeds. OptiCHO with the addition of the recommended feed
(EfficientFeed A) did not increase titers or cell concentrations
in the samemanner as ActiCHO Pwith FeedA and B. Instead,
the combination of OptiCHO and EfficientFeed A resulted in
the least productive fed-batch with a volumetric productivity
of 50 mg/L/day (Table 4). In contrast, propagation in
ActiCHO P combined with Feed A and B or an additional
supplementation with FunctionMAX reached almost seven-
fold higher values. Other combinations of OptiCHO such as
feeding with EfficientFeed A and FunctionMAX or Feed A
and B elevated the STY about twofold indicating that the
underlying basal medium is important for the success of the
applied feed strategy. As shown by the results from OptiCHO,
a feeding strategy, for example, with the use of either
FunctionMAX or Feed A and B can still boost the volumetric
productivity. Yet, an optimized basal medium and feed com-
bination resulted in an up to sevenfold increase, as shown by
the example of ActiCHO P with the tested feed combinations.
Proliferating cells often ingest more nutrients than are
bioenergetically needed and shunt metabolites into biosyn-
thetic pathways (Bauer et al . 2004; Shaw 2006;
DeBerardinis et al. 2008; Vander Heiden et al. 2009). The high
glycolytic flux triggers the cells to the excessive accumulation
of pyruvate, which is secreted as lactate (DeBerardinis et al.
2008). We found remarkably similar glucose consumption
rates (Table 4), but substantially different cell-specific lactate
production rates in the investigated media and feed combina-
tions. The feeds had a drastic influence causing a fourfold
difference between the lowest lactate production rate in
OptiCHO supplemented with EfficientFeed A and
FunctionMAX compared to the highest production rate when
cultures in OptiCHO were fed with Feed A and B. A possible
explanation is that in this basal medium, cells did not grow
sufficiently fast to consume all the nutrients supplied by the
daily addition of Feed A and B. Nutrient overfeeding may
shift cells to a less efficient energy metabolism and led to high
osmolality, which can trigger higher lactate productivities as
discussed further in this section.
The specific consumption rate of glutamine, which has
been described to contribute substantially to lactate production
(Dean and Reddy 2013), was similar in all media. The devel-
opment of ammonium concentrations showed substantial dif-
ferences in fed-batch cultures grown in either OptiCHO fed or
ActiCHO P (Fig. 2e). This suggests that in addition to the feed
additives, the basal medium can substantially contribute to the
ammonium metabolism of the cells. Despite lower cell con-
centrations in OptiCHO, ammonium increased drastically dur-
ing the stationary phase of the cultures (Fig. 2e) with occa-
sionally sixfold higher specific production rates than in
ActiCHO P (data not shown). Recently, the production of
ammonium and also alanine was linked to the consumption
of aspartate and glutamic acid in a glutamine synthetase CHO
cell line (Duarte et al. 2014). In our experiments, similar ob-
servations were made for the concentration of alanine, which
increased in all cultures. Furthermore, higher Asp consump-
tion was found in OptiCHO fed-batches than in ActiCHO P
cultures, which makes alanine a potential source for ammoni-
um. However, in our case, the specific Glu consumption rates
did not correlate well with the specific ammonium production
rates (Table 4).
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Although low lactate concentrations are generally desired
in bioprocessing, our data and work previously published by
Li et al. (2012) showed that a total depletion can coincide with
increased ammonium levels. Xing et al. (2008) found that
ammonium levels above 5.1 mM (92 mg/L) can inhibit cell
growth. This threshold was passed on day 7 in OptiCHO fed-
batches and indeed coincided with peak cell concentrations
that declined thereafter. However, cell viability and antibody
production were not negatively impacted.
Cell cultures grown in OptiCHO and supplemented with
Feed A and B accumulated glutamic acid, ammonium, and
lactate throughout the process and the concentrations were
higher than in any other fed-batch (Fig. 2d–f). In parallel,
the osmolality increased steadily (Fig. 2c). In most cell culture
media, the osmolality ranges between 270 and 330 mOsm/kg,
and it has been shown that increased levels can severely re-
duce specific cell growth rates (Kim et al. 1998; Kim and Lee
2002; Zhu et al. 2005). The suggested inhibitory threshold for
affecting cell viability negatively was reported to be
380 mOsm/kg (Xing et al. 2008). In two of the evaluated
fed-batch cultures this osmolality was exceeded 1 day after
the end of the exponential growth phase, and this observation
coincided with declining cell concentrations. However, the
cell viability was not affected and remained above 90 % for
the following 4 to 6 days (data not shown). The steadily in-
creasing osmolality in OptiCHO fed-batches supplemented
with Feed A and B was most likely the result of a constant
feeding regimen. Already on day 5, 15 of 18 measured amino
acids were 200–500 % higher than in the original medium
composition and the remaining three close to their original
concentrations (Table 3C). As discussed above, this might
have induced cellular stress, leading to a less efficient glucose
metabolism and the resulting high lactate concentration
(Fig. 2d). This hypothesis is supported by the twofold to
fourfold increase in cell-specific lactate production compared
with the other fed-batch strategies studied, despite similar spe-
cific glucose consumption rates.
Protein glycosylation is an important post-translational
modification, as sugar residues are involved in many process-
es such as recognition and biological regulation. The glycan
structures also determine certain properties of the recombinant
protein including immunogenicity, efficacy, and serum half-
life. Therefore, it is desired to control glycosylation tightly,
thus contributing to constant quality of the recombinant
glyco-protein. Cellular glycosylation can be affected by nu-
merous factors like the host cell line, protein structure, medi-
um components, and culture conditions (Butler and Spearman
2014). The three main glycan structures observed in our ex-
periments were G0F, G1F, and G2F (Fig. 3). Similar observa-
tions were reported previously (Costa et al. 2013). Core
fucosylation is a typical attribute of CHO-expressed proteins.
However, studies have shown that defucosylated antibodies
exert an up to 100-fold improved antibody-dependent cellular
cytotoxicity (ADCC) (Shields et al. 2002) and defucosylated
glycans are therefore desired for therapeutics that rely on this
effect. Increased amounts of high mannose structures may
reduce ADCC and complement-dependent cytotoxicity
(CDC) (Kanda et al. 2007). Additionally, high mannose struc-
tures can result in higher clearance rates (Goetze et al. 2011).
The levels of high mannose glycans for endogenous human
IgG is less than 0.1 % but can range from 1 % to greater than
20 % in recombinant antibodies (Flynn et al. 2010). Low to
medium levels of mannose 5 (Man5) modified IgG (3 to 9 %)
were observed in our experiments. In general, the concentra-
tion of high mannose structures was reduced by about 50 % in
cultures grown in ActiCHO P (Fig. 3). Terminal
galactosylation is not yet fully understood (Costa et al.
2013). However, as agalactosylated (G0) structures in













Peak cell conc. (107 cells/mL) 2.39 2.13 0.58 0.57 0.68 0.90
Antibody conc. (g/L) 5.48 5.82 0.72 0.80 1.74 1.46
μ exponential phase (1/d) 0.63 0.65 0.40 0.38 0.43 0.46
qP exp. phase (pg/(cell×day)) 51.2 51.2 31.7 29.9 36.7 39.3
qP whole process (pg/(cell×day)) 43.9 46.9 27.4 28.8 35.6 31.0
STY (mg/(L×d)) 344.7 281.8 51.4 50.0 81.5 97.3
qGlucosea (pg/(cell×day)) −312.2 −303.0 −252.6 −259.5 −312.9 −294.1
qLactatea (pg/(cell×day)) 59.2 52.3 56.5 55.1 33.0 134.3
qGlutamatea (pg/(cell×day)) −10.9 −14.0 −28.4 −21.0 −12.6 −8.0
qGlutaminea (pg/(cell×day)) −30.4 −22.7 −30.9 −31.4 −32.3 −30.3
qAmmoniuma (pg/(cell×day)) 3.2 3.2 8.2 5.4 4.7 7.6
STY space-time yield
aMean values calculated starting from feed start (day 3) over the duration of the complete fed batch culture
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antibodies have been associated with several pathologies
(Parekh et al. 1985), higher galactosylated (G1, G2) antibod-
ies are generally preferred. The glycan distribution with the
lowest G0F, but highest G1F/G2F structures, were found in
ActiCHO P supplemented with Feed A and B, and in
OptiCHO fed with EfficientFeed A for 9 days (Fig. 3).
However, the higher Man5 percentage found in antibodies in
the latter combination should be considered critical in case of
in vivo experiments.
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